Coffee intake, recurrence, and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Journal of Clinical Oncology

Volumn 33, Issue 31, 2015, Pages 3598-3607

  Guercio, Brendan J ^a   Sato, Kaori ^a,b   Niedzwiecki, Donna ^l   Ye, Xing ^l   Saltz, Leonard B ^e   Mayer, Robert J ^b   Mowat, Rex B ^f   Whittom, Renaud ^g   Hantel, Alexander ^h   Benson, Al ⁱ   Atienza, Daniel ^k   Messino, Michael ^m   Kindler, Hedy ^j   Venook, Alan ⁿ   Hu, Frank B ^c   Ogino, Shuji ^b,c,d   Wu, Kana ^c   Willett, Walter C ^c   Giovannucci, Edward L ^a,c,d   Meyerhardt, Jeffrey A ^b   Fuchs, Charles S ^b   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f Toledo Community Hospital Oncology Program   (United States)

^g HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^h LOYOLA UNIVERSITY CHICAGO   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k Virginia Oncology Associates   (United States)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m Mission Hospital   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; ANTINEOPLASTIC AGENT; CAFFEINE; COFFEE; TEA;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; COFFEE; COHORT ANALYSIS; COLON CANCER; DIETARY INTAKE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; RISK FACTOR; SURVIVAL RATE; TEA; ADJUVANT CHEMOTHERAPY; COLONIC NEOPLASMS; CONTROLLED STUDY; DIET; LIFESTYLE; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAFFEINE; CHEMOTHERAPY, ADJUVANT; COFFEE; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DIET; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TEA; YOUNG ADULT;

EID: 84947282178     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.61.5062     Document Type: Article

References (60)

1. Chan AT, Giovannucci EL: Primary prevention of colorectal cancer. Gastroenterology 138:2029-2043.e10, 2010
2. Giovannucci E: Diet, body weight, and colorectal cancer: A summary of the epidemiologic evidence. J Womens Health 12:173-182, 2003
3. Moghaddam AA, Woodward M, Huxley R: Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16:2533-2547, 2007
4. Samad A, Taylor R, Marshall T, et al: A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7:204-213, 2005
5. Giovannucci E: Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 131:3109S-3120S, 2001
6. Kaaks R, Toniolo P, Akhmedkhanov A, et al: Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592-1600, 2000
7. Jenab M, Riboli E, Cleveland RJ, et al: Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:368-376, 2007
8. Otani T, Iwasaki M, Sasazuki S, et al: Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective study. Int J Cancer 120:2007-2012, 2007
9. Wei EK, Ma J, Pollak MN, et al: A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14:850-855, 2005
10. Le Marchand L, Wang H, Rinaldi S, et al: Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population. Cancer Epidemiol Biomarkers Prev 19: 1471-1477, 2010
11. Fung TT, Hu FB, Schulze M, et al: A dietary pattern that is associated with C-peptide and risk of colorectal cancer in women. Cancer Causes Control 23:959-965, 2012
12. Demark-Wahnefried W, Platz EA, Ligibel JA, et al: The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 21: 1244-1259, 2012
13. Fuchs MA, Sato K, Niedzwiecki D, et al: Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance). PLoS One 9:e99816, 2014
14. Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 298:754-764, 2007
15. Wolpin BM, Meyerhardt JA, Chan AT, et al: Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27:176-185, 2009
16. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Clin Oncol 24:3535-3541, 2006
17. Mills KT, Bellows CF, Hoffman AE, et al: Diabetes mellitus and colorectal cancer prognosis: A meta-analysis. Dis Colon Rectum 56:1304-1319, 2013
18. Bhupathiraju SN, Pan A, Manson JE, et al: Changes in coffee intake and subsequent risk of type 2 diabetes: Three large cohorts of US men and women. Diabetologia 57:1346-1354, 2014
19. Ding M, Bhupathiraju SN, Chen M, et al: Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and a dose-response meta-analysis. Diabetes Care 37: 569-586, 2014
20. Bhupathiraju SN, Pan A, Malik VS, et al: Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 97:155-166, 2012
21. van Dam RM, Hu FB: Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA 294:97-104, 2005
22. Salazar-Martinez E, Willett WC, Ascherio A, et al: Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140:1-8, 2004
23. Wu T, Willett WC, Hankinson SE, et al: Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in US women. Diabetes Care 28: 1390-1396, 2005
24. Wedick NM, Brennan AM, Sun Q, et al: Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: A randomized controlled trial. Nutr J 10:93, 2011
25. Williams CJ, Fargnoli JL, Hwang JJ, et al: Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: A prospective cohort study. Diabetes Care 31:504-507, 2008
26. Yu X, Bao Z, Zou J, et al: Coffee consumption and risk of cancers: A meta-analysis of cohort studies. BMC Cancer 11:96, 2011
27. Li G, Ma D, Zhang Y, et al: Coffee consumption and risk of colorectal cancer: A meta-analysis of observational studies. Public Health Nutr 16:346-357, 2013
28. Je Y, Liu W, Giovannucci E: Coffee consumption and risk of colorectal cancer: A systematic review and meta-analysis of prospective cohort studies. Int J Cancer 124:1662-1668, 2009
29. Saltz LB, Niedzwiecki D, Hollis D, et al: Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803. J Clin Oncol 25:3456-3461, 2007
30. Zubrod CG, Schneiderman M, Frei E III, et al: Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 11:7-33, 1960
31. Meyerhardt JA, Sato K, Niedzwiecki D, et al: Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Natl Cancer Inst 104:1702-1711, 2012
32. Willett WC, Sampson L, Stampfer MJ, et al: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65, 1985
33. Willett WC, Reynolds RD, Cottrell-Hoehner S, et al: Validation of a semi-quantitative food frequency questionnaire: Comparison with a 1-year diet record. J Am Diet Assoc 87:43-47, 1987
34. US Department of Agriculture ARS: USDA nutrient database for standard reference, release 10. http://www.nal.usda.gov/fnic/foodcomp
35. US Department of Agriculture. Composition of foods: raw, processed, and prepared, 1963-1988. Agriculture Handbook No. 8 Series. Washington, DC, Department of Agriculture, US Government Printing Office, 1989
36. Willett W, Stampfer MJ: Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 124:17-27, 1986
37. Salvini S, Hunter DJ, Sampson L, et al: Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol 18:858-867, 1989
38. Michaud DS, Fuchs CS, Liu S, et al: Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 14:138-147, 2005
39. Oh K, Willett WC, Fuchs CS, et al: Glycemic index, glycemic load, and carbohydrate intake in relation to risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 13: 1192-1198, 2004
40. Hu FB, Stampfer MJ, Rimm E, et al: Dietary fat and coronary heart disease: A comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531-540, 1999
41. National Cancer Institute: Tea and cancer prevention: Strengths and limits of the evidence. http://www.cancer.gov/cancertopics/factsheet/prevention/tea
42. van Dam RM, Willett WC, Manson JE, et al: Coffee, caffeine, and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged US women. Diabetes Care 29:398-403, 2006
43. Kontou N, Psaltopoulou T, Soupos N, et al: The role of number of meals, coffee intake, salt and type of cookware on colorectal cancer development in the context of the Mediterranean diet. Public Health Nutr 16:928-935, 2013
44. Sugiyama K, Kuriyama S, Akhter M, et al: Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr 140:1007-1013, 2010
45. Michels KB, Willett WC, Fuchs CS, et al: Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 97:282-292, 2005
46. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
47. Ainsworth BE, Haskell WL, Leon AS, et al: Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc 25:71-80, 1993
48. Keijzers GB, De Galan BE, Tack CJ, et al: Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25:364-369, 2002
49. Huxley R, Lee CMY, Barzi F, et al: Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis. Arch Intern Med 169:2053-2063, 2009
50. Zhang WL, Lopez-Garcia E, Li TY, et al: Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia 52:810-817, 2009
51. Tunnicliffe JM, Eller LK, Reimer RA, et al: Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats. Appl Physiol Nutr Metab 36:650-659, 2011
52. Johnston KL, Clifford MN, Morgan LM: Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: Glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78:728-733, 2003
53. Lopez-Garcia E, van Dam RM, Qi L, et al: Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84:888-893, 2006
54. Svilaas A, Sakhi AK, Andersen LF, et al: Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134:562-567, 2004
55. Olthof MR, Hollman PC, Katan MB: Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131:66-71, 2001
56. Bøhn SK, Blomhoff R, Paur I: Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58:915-930, 2014
57. La Vecchia C, Tavani A: Coffee and cancer risk: An update. Eur J Cancer Prev 16:385-389, 2007
58. Nkondjock A: Coffee consumption and the risk of cancer: An overview. Cancer Lett 277:121-125, 2009
59. Hu FB, Rimm E, Smith-Warner SA, et al: Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 69:243-249, 1999
60. Weismayer C, Anderson JG, Wolk A: Changes in the stability of dietary patterns in a study of middle-aged Swedish women. J Nutr 136:1582-1587, 2006